倍道而進|第一屆西湖-新英格蘭 臨床蛋白質組大數據暑期培訓班

2021-02-24 鹿明生物

Hannes Röst

http://www.roestlab.org/index.html

多倫多大學(University of Toronto)

Hannes Röst在蘇黎世聯邦理工學院獲得生物化學學士學位和生物信息學碩士學位,並在蘇黎世聯邦理工學院Ruedi Aebersold教授實驗室獲得博士學位,他開發了新的計算方法來分析基於質譜的蛋白質組學數據。這項工作使研究人員能夠將目標蛋白質組學實驗的通量提高100倍,並增加可在一項研究中分析的樣本數量。獲得博士學位後,他加入了史丹福大學Mike Snyder教授的實驗室,將他的工作應用於個性化醫療領域。在史丹福大學,Hannes專注於開發用於處理的計算工具,管理和分析大型,異構和縱向數據集。他在多倫多大學的研究探索了能力新穎的質譜方法,以獲得高度定量的蛋白質組學和代謝組學數據矩陣,並使用這些定量數據來解決系統生物學和個性化醫學中的問題。

Hannes Röst obtained a BSc in Biochemistry and a MSc in Bioinformatics from ETH Zurich, and during his PhD in the lab of Prof. Ruedi Aebersold at ETH Zurich, he developed novel computational methods to analyze mass spectrometry-based proteomics data. This work has allowed researchers to increase throughput of targeted proteomics experiments by up to 100-fold and increase the number of samples that could be analyzed in a single study. After his PhD, he joined the lab of Prof. Mike Snyder at Stanford University to apply his work in the area of personalized medicine. In Stanford, Hannes focused on developing computational tools for handling, managing and analyzing large, heterogeneous and longitudinal datasets. His research at University of Toronto explore the capability novel mass spectrometric methods to obtain highly quantitative proteomics and metabolomics data matrices and use these quantitative data to address questions in systems biology and personalized medicine.


趙劍飛(Jianfei Zhao)

NEJM醫學前沿(NEJM Frontiers in Medicine)

《NEJM醫學前沿》副主編,全面負責雜誌出版方面的相關運作,包括內容運營管理、戰略規劃和品牌推廣。此前,在自然雜誌社旗下的《自然通訊》雜誌擔任專職科學編輯,審閱來自世界各國的表觀遺傳學等生物領域論文。作為自然雜誌社首位落地中國的生命科學領域編輯,與中國生命科學界的科研人員建立了密切聯繫。本科畢業於北京大學,在美國俄勒岡大學獲得博士學位,隨後在美國國立癌症研究所從事博士後研究,專注於表觀遺傳因素對基因表達調控的影響。

Deputy Editor, NEJM. Responsible for the daily operation of the digital platform, including content operation, strategic planning and outreach. Previously, he was a scientific editor at Nature Communications, Nature Publishing Group (NPG), managing the evaluation and review of manuscripts in biology, focusing on epigenetics, submitted around the world. As the first biology editor of NPG working in China, he fostered close relationships with the life sciences community in China. He obtained a B.Sc in Peking University, and a Ph.D. in University of Oregon, the United States. His postdoctoral training in the US National Cancer Institute is centered on the epigenetic regulation of gene expression.


Linda Wu

NEJM醫學前沿(NEJM Frontiers in Medicine)

現任《NEJM醫學前沿》臨床研究顧問,國際臨床研究護理協會全球發展小組共同主席及核心課程評審員。美國明尼蘇達大學護理學碩士。曾創建美國洛瑪連達大學(Loma Linda University)醫療臨床試驗中心,並任首位主任;曾任新加坡國立臨床試驗中心(CTERU)項目協調主任。從事臨床試驗規劃籌備協調及行政管理逾20年。兼任Loma Linda大學倫理委員會委員。近年來積極致力於提倡臨床研究專業認可,參與臨床研究專業人員培訓及機構管理架構。

Wu is an advisor for NEJM XYQY. As a consultant, her work has been focusing on clinical research education and program development as well as giving lectures regarding these topics. She also serves as a member of institution review board (IRB) at the Loma Linda University in California and co-chair for the International Association of Clinical Research Nurses (IACRN) Global Development Workgroup. Prior to becoming a consultant, she was the founding director of the Loma Linda University Clinical Trial Center from 2008 to 2015. In addition to her consultant work, Ms. Wu is passionate about the development of clinical research nurse and coordinator profession. She advocates the importance of CRN/ CRC in the clinical research enterprise as well as participate organized effort to make changes with like-minded field leaders through IACRN.

李文慶(Wenqing Li)

北京大學腫瘤醫院、北京大學國際癌症研究中心(Peking University Cancer Hospital and Peking University International Cancer Research Center)

北京大學腫瘤醫院研究員、博士生導師、北京大學國際癌症研究中心PI。美國哈佛醫學院和國立癌症研究所博士後,歸國前任常青藤名校布朗大學助理教授、博士生導師。2016年入選中組部國家「千人計劃」青年人才,2018年入選北京市「海聚工程」全職工作類,獲聘為北京市特聘專家。現任中國抗癌協會青年理事會副理事長、北京抗癌協會青年理事會副理事長兼秘書長、中國抗癌協會腫瘤流行病學專委會以及胃癌專委會基礎與病理學組委員、中國環境誘變劑學會生物標誌物專委會委員和青委會副主任委員。

PhD. Principal Investigator at the Peking University Cancer Hospital and Peking University International Cancer Research Center. Before returning to China, he was an assistant professor at Brown University. He is the Vice Chair of the Youth Council of the China Anti-Cancer Association, the Vice Chair and Secretary General of the Youth Council of the Beijing Anti-Cancer Association, a member of the Cancer Epidemiology Committee and the Basic Research and Pathology Group of the Gastric Cancer Committee of the China Anti-Cancer Association, and a member of the Environmental Mutagen Society Biomarker Committee and Deputy President of its Youth Committee. He has been awarded several prestigious awards, including 「Young One Thousand Talents Program」 and 「Beijing Haiju Project」 (full-time employment category). He was a postdoctoral fellow at the Harvard Medical School and the US National Cancer Institute.

Limsoon Wong

limsoon@nus.edu.sg

https://www.comp.nus.edu.sg/~wongls/

National University of Singapore

Limsoon Wong is Kwan-Im-Thong-Hood-Cho-Temple Chair Professor in the School of Computing at the National University of Singapore (NUS). He was also a professor (now honorary) of pathology in the Yong Loo Lin School of Medicine at NUS. Before coming to NUS, he was the Deputy Executive Director for Research at A*STAR's Institute for Infocomm Research. He currently works mostly on knowledge discovery technologies and their application to biomedicine. He has also done, in the earlier part of his career, significant research in database query language theory and finite model theory, as well as significant development work in broad-scale data integration systems. Limsoon has written about 300 research papers, some of which are among the best cited of their respective fields. Limsoon is a Fellow of the ACM, named in 2013 for his contributions to database theory and computational biology. Some of his other recent awards include the 2003 FEER Asian Innovation Gold Award for his work on treatment optimization of childhood leukemias, the 2006 Singapore Youth Award Medal of Commendation for his sustained contributions to science and technology, and the ICDT 2014 Test of Time Award for his work on naturally embedded query languages. He was also conferred, in 2014, a Public Administration Medal (Bronze) by the Singapore Government for outstanding efficiency, competence, and industry. He serves/served on the editorial boards of Journal of Bioinformatics and Computational Biology, Bioinformatics, Biology Direct, Drug Discovery Today, IEEE/ACM Transactions on Computational Biology and Bioinformatics, Genomics Proteomics & Bioinformatics, Journal of Biomedical Semantics, Methods, Scientific Reports, Information Systems, and IEEE Transactions on Big Data. He is also an ACM Books Area Editor. Limsoon received his BSc(Eng) in 1988 from Imperial College London and his PhD in 1994 from University of Pennsylvania.

吳健民(Jianmin Wu)

https://www.researchgate.net/profile/Jianmin_Wu3

北京大學腫瘤醫院、北京大學國際癌症研究中心(Peking University Cancer Hospital and Peking University International Cancer Research Center)

吳健民,研究員、博士研究生導師,北京大學腫瘤醫院腫瘤生物信息中心主任,兼信息部副主任。致力於綜合計算和實驗手段,整合多組學和臨床數據深入研究國內高發癌種的發病機制、精準分子分型和個體化治療。擔任國際癌症基因組聯盟(ICGC) 癌症基因組加速研究計劃(ARGO)委員會委員,在大隊列的癌症基因組、蛋白組及相關生物信息學研究上有豐富經驗。通訊作者研究成果先後在Nature Methods、Nature Reviews Cancer (Analysis Article,封面文章)、Nucleic Acids Research 等雜誌發表;合作研究多次在Nature (4次)和Cell (2014)等雜誌發表。共發表SCI論文40餘篇,他引大於2000次,單篇最高引用775次。

Director of Cancer Bioinformatics Center, Peking University Cancer Hospital. Dr. Wu is a senior bioinformatician focusing on data-driven cancer research, which combines high-throughput genomic, transcriptomic and proteomic profiling approaches, to comprehensively investigate molecular landscapes of GI cancer and identify prognosis/predictive biomarkers and novel therapeutic targets. He published 40+ publications in peer reviewed journals with >2000 citations, including corresponding author work in NatureMethods, Nature Reviews Cancer and Nucleic Acids Research et al. , and collaborative work in Nature (4) and Cell. He is also a scientific planning committee member of International Cancer Genome Consortium (ICGC) - Accelerating Research in Genomic Oncology (ARGO) initiative.

常乘(Cheng Chang)

https://orcid.org/0000-0002-0361-2438

國家蛋白質科學中心-北京(National Center for Protein Sciences (Beijing))

2010年畢業於湖南大學電子信息工程專業,獲學士學位。2010年-2015年就讀於北京蛋白質組研究中心,專業生物信息學。2015年博士畢業後任國家蛋白質科學中心-北京(鳳凰中心)助理研究員,研究方向:生物信息學、蛋白質組學、系統生物學。自2015年以來,他已在無標定量、有標定量、差異蛋白質篩選、定量結果富集分析及可視化等方面提出了一系列新算法,研發了有標定量工具SILVER,蛋白質無標定量算法LFAQ,綜合性定量軟體包PANDA以及定量結果統計分析及可視化工具PANDA-view,蛋白質相互作用網絡分析工具PPIExp,蛋白質相互作用文獻挖掘工具PPICurator;主持國家自然科學基金青年項目一項、蛋白質組學國家重點實驗室自主研究課題一項,參與973、863、國際科技合作、國家重點研發計劃等項目多項,以第一及通訊作者(含共同)在Bioinformatics, Analytical Chemistry, Journal of Proteome Research, Proteomics等期刊上發表論文12篇,獲得軟體著作權授權6項,申請國家發明專利3項。曾獲2016年第九屆中國蛋白質組學大會「優秀青年學者報告獎」。

Dr Cheng Chang is an assistant research fellow at National Center for Protein Sciences (Beijing) focusing on bioinformatics, proteomics and system biology. Since 2015, Dr Chang has proposed novel algorithms and developed easy-to-use tools for both label-free and labeled quantifications, as well as the post-processes of quantification results, such as LFAQ for label-free absolute protein quantification and PANDA for both labeled and label-free quantitative proteomics data analysis. As the first or corresponding authors, he published 12 papers in journals such as Bioinformatics, Analytical Chemistry, Journal of Proteome Research, Proteomics, etc., and obtained 6 software copyright licenses. He was awarded the Young Investigator Award at the 9th CNHUPO in 2016.

Wilson Goh

https://sites.google.com/site/gohwenbinwilson/home

新加坡南洋理工大學(Nanyang Technological University)

Wilson GOH是南洋理工大學生物科學學院的教員。他的研究興趣在於應用生物統計學,網絡理論和綜合「多組學」。他於2005年獲得新加坡國立大學的生命科學學士學位,並於2014年獲得倫敦帝國理工學院的理學碩士/博士學位(生物信息學和理論系統生物學)。

Wilson Wen Bin Goh is a faculty member of the School of Biological Sciences, Nanyang Technological University. His research interests lies in applied biostatistics, network theory and integrative 「multi-omics」. He received his BSc (Life Sciences) in 2005 from the National University of Singapore and his MSc/PhD (Bioinformatics and Theoretical Systems Biology) in 2014 from the Imperial College London.

沈誠頻(Chengpin Shen)

易算生物(Omicsolution)首席技術官

本科及博士就讀於復旦大學化學系、生物醫學研究院,MIT訪問學者。自2005年起從事蛋白質組學相關研究工作,2016年創辦易算生物,與瑞士Biognosys公司合作,在國內致力於推廣基於SWATH/DIA技術的蛋白質組定量解決方案。(www.omicsolution.com)

Dr Shen received his bachelor and PhD degree from Department of Chemistry, Institutes of Biomedical Sciences, Fudan University, and visiting scholar of Massachusetts institute of technology. He has been engaged in proteomics research since 2005 and established Omicsolution in 2016. With the cooperation with Biognosys from Switzerland, he popularized a total solution of quantitative proteomics based on SWATH/DIA technology in China.

陳晨(Chen Chen)

SCIEX

高級應用工程師,2015年於武漢大學獲得生物化學與分子生物學博士學位。現就職於SCIEX中國應用支持團隊,負責蛋白質組學的應用支持工作,擁有9年基於質譜的蛋白質組學研究經驗。

Senior Application Engineer, Ph.D. in Biochemistry and Molecular Biology from Wuhan University in 2015. Currently working for SCIEX China Application Support Team, responsible for proteomics application support, with 9 years of experience in mass spectrometry-based proteomics research.

劉一穎(Yiying Liu)

SCIEX 

應用工程師,復旦大學分析化學博士,生物醫學研究院博士後。自2012年開始從事膜蛋白組學的研究,具有豐富的項目開發和故障排查經驗。

Application Engineer,PhD in Analytical Chemistry. Dr. Liu has engaged in the research of membrane proteomics since 2012 in Department of Chemistry & Institutes of Biomedical Sciences, Fudan University. She has extensive experience in method development and troubleshooting.

朱天生(Tiansheng Zhu)

http://www.guomics.com/nd.jsp?id=16#_jcp=1

西湖大學(Westlake University)

本碩畢業於華中農業大學作物生物技術專業,博士在讀於復旦大學計算機軟體與理論專業。2017年9月,作為資深科研助理加入西湖大學郭天南實驗室,主要研究蛋白質組大數據的處理和分析。

Tiansheng received training of biotechnology in Huazhong Agricultural University (HZAU), and learned computer science in Fudan University, China. He worked on data management in the data center Department of Shanghai bioinformatics research center. After that, he was engaged in the construction and management of data platform in Shanghai Academy of Agricultural Sciences. Tiansheng joined the Guomics team in September 2017 as a senior research assistant, and mainly works in proteomic big data science.

陳浩(Hao Chen)

http://www.guomics.com/nd.jsp?id=73#_jcp=1

西湖大學(Westlake University)

陳浩在NGS行業工作6年,具有面向對象編程(c#、c++)和腳本編程(perl、R、Python或bash)方面的工作經驗,擅長生物信息大數據分析平臺建設,目前主要從事蛋白質組大數據挖掘工作。

Hao has worked in NGS industry for 6 years, with rich experience in object-oriented programming (C#,C++) and scripting (perl, R, Python and bash). He is good at building bioinformatics pipelines. Now he is working on proteomic data mining.

陸妙善(Miaoshan Lu)

西湖大學(Westlake University)

2010-2013年,創立南京魔韻軟體科技有限公司,擔任公司COO營運長;2008-2014年碩士研究生畢業於南京大學軟體工程學院2014-2018年在阿里巴巴從事軟體研發相關工作;2014-2015年在電子憑證交易團隊擔任研發工程師(P5);2015-2016年分別在O2O團隊和商品中心團隊擔任資深研發工程師(P6);2016-2018年在國際化Lazada團隊擔任技術專家,移動端開發組Team Leader(P7);2018年1月1日從阿里巴巴辭職,提前進入西湖大學於長斌實驗室從事博士相關的工作;2018年9月正式進入西湖大學讀博,成為西湖二期的成員。

Miaoshan founded nanjing moyun software technology co., ltd and served as the COO of the company(2010-2013) and learned software engineering(2008-2014)in Nanjing University. In 2014, Miaoshan started his 4 years career as software researcher in alibaba. He worked as a software researcher(P5) in the electronic certificate trading team(2014-2015), and served as senior engineer in O2O(Online to Offline & Offline to Online) team and alibaba commodity center team respectively. From 2016 to 2018, he worked as a technical expert in the international Lazada Team and the Team Leader of the Lazada-Seller-MobileTeam. He resigned from alibaba in 2018.1.1, and entered Westlake University to do PhD related work ahead of schedule. In 2018.9, He officially entered the Westlake University as a doctoral candidate and became a member of the Phase 2 of Westlake University.

王瑞敏(Ruimin Wang)

西湖大學(Westlake University)

西湖大學-復旦大學2017級跨學科聯合培養攻讀博士學位研究生,人工智慧與機器人中心於長斌實驗室首批博士生,2017年畢業於中國科學技術大學計算機科學與技術專業,主要研究方向是質譜數據的分析算法。

Ruimin received bachelor's degree in Computer Science from University of Science and Technology of China in 2017 and joined Westlake University as a PhD student, mainly engaged in analyzing algorithm of MS data.

鄭鉅聖 (Jusheng Zheng)

http://www.wias.org.cn/wap/index.php?a=kydetail&catid=490&id=8792&web=english

西湖大學(Westlake University)

2009年畢業於寧波大學,獲得學士學位;2014年畢業於浙江大學,獲得博士學位,從事營養流行病學研究;2011-2012年,作為聯合培養博士生,在美國塔夫茨大學人類老年營養研究中心從事營養遺傳學研究;2015年-2018年在英國劍橋大學臨床醫學院從事遺傳流行病學和營養學博士後研究工作,歐盟瑪麗居裡學者(Marie Skłodowska-Curie Individual Fellow)。2018年9月加入西湖大學生命科學學院,擔任獨立課題組負責人(PI)、特聘研究員、博士生導師,成立人類營養與流行病實驗室(實驗室網站:www.wenutrition.net)

Ju-Sheng completed his PhD degree in nutrition at Zhejiang University (Hangzhou, China). Within his PhD program, he received one year’s training in the Nutrition and Genomics Lab at Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University in the USA, where he worked on the project of gene-nutrient interaction on diabetes traits. He is also a Marie Skłodowska-Curie Individual Fellow supported by the European Commission (2016-2018), and receiving postdoctoral training at the MRC Epidemiology Unit, University of Cambridge, UK.

Ju-Sheng joined the School of Life Sciences at Westlake University in September 2018 and has been leading the Laboratory of Human Nutrition and Epidemiology at Westlake University.

相關焦點

  • 第二屆西湖臨床質譜研討會
    Progresses and Perspectives ofMass Spectrometry-basedClinical Proteomics基於質譜的臨床蛋白質組學的研究進展與展望
  • 第七屆中國蛋白質組學大會第二輪通知
    蛋白質組學與轉化醫學第七屆中國蛋白質組學大會暨第三屆國際蛋白質組學論壇  (第二輪通知)  為積極促進蛋白質組學的研究與發展,增進國際間合作交流,由中國生物化學與分子生物學會蛋白質組學專業委員會(CNHUPO)和國際蛋白質組學論壇
  • Cell:西湖大學再獲重大突破!解密新冠肺炎患者血清的蛋白質組和...
    為了驗證這一推測,他們應用蛋白質組學和代謝組學技術分析了來自COVID-19患者和幾個對照組的血清的蛋白質組和代謝組。 相關研究結果於2020年5月27日在線發表在Cell期刊上,論文標題為「Proteomic and Metabolomic Characterization of COVID-19 Patient Sera」。
  • 想前往西湖大學暑期實習嗎?機會來了
    因此,西湖大學此次除了面向大二、大三的本科生,還特別開放名額,邀請這些因新冠疫情打斷海外博士求學之旅的優秀學子,可以先來西湖大學看看,感受一下這裡的科研氛圍。那麼今年暑期西湖大學42個實驗室都開放哪些項目呢?
  • Cell西湖大學郭天南等首次揭示新冠患者蛋白質分子病理全景圖
    這是在全球範圍內第一次從蛋白質分子水平上,對新冠病毒感染人體後多個關鍵器官做出的響應進行了詳細和系統的分析,為臨床工作者和研究人員制定治療方案、開發新的藥物及治療方法提供了線索和依據。
  • 北極狼運動俱樂部遊泳暑期培訓班招生簡章
    北極狼運動俱樂部北極狼遊泳培訓班開班了! 2014年北極狼運動俱樂部成為梅縣區青少年遊泳隊的指定訓練俱樂部參加梅州市第七屆運動會,此次市運會得到梅縣區體育局和勇興集團—新城健身中心的大力支持,為了答謝廣大新老學員,北極狼運動俱樂部將抽派幾名教練員為暑期遊泳培訓班進行專業培訓,並將在今年暑期遊泳培訓班中為梅縣區遊泳隊選拔和輸送人才,請廣大新老學員珍惜機會,我們將用心為您的孩子服務
  • 【開明e講堂】民進會員西湖大學鄭厚峰團隊用大數據研究終結爭論...
    西湖大學生命科學學院PI鄭厚峰為此文通訊作者,2018級博士研究生夏江威為第一作者。西湖大學為此項研究工作的獨立通訊單位。參與單位包括密西根大學、浙二醫院、濱州醫學院和江西醫學高等專科學校等。西湖大學超算中心亦為項目提供技術支持。為什麼做皮膚病與骨質疏鬆關係的研究呢?
  • Cell重磅:西湖大學首次揭示新冠患者蛋白質分子病理全景圖
    相當於他們將醫生在顯微鏡下看到的人體感染新冠後細胞組織的改變放大了數萬倍,達到蛋白質分子層面,「看」清楚是哪些分子的改變導致人體器官的病變和衰竭。 這是在全球範圍內第一次從蛋白質分子水平上,對新冠病毒感染人體後多個關鍵器官做出的響應進行了詳細和系統的分析,為臨床工作者和研究人員制定治療方案、開發新的藥物及治療方法提供了線索和依據。
  • SWATH採集技術在蛋白質組學中的應用
    其中2014年在Nature/Scientific Data[1]發表的文獻中展示了:SWATH-MS同時定量一萬種以上人體內蛋白質,該方法庫涵蓋了蛋白(UniProtKB/SwissProt)資料庫裡注釋的50.9%的人蛋白質。因此,有望被廣泛的應用於基礎或者臨床研究。
  • 中國人類蛋白質組學研究新突破三大看點
    新華社北京3月2日電 題:「發現肝細胞癌精準治療潛在新靶點!」——中國人類蛋白質組學研究新突破三大看點  新華社記者 陳芳、胡喆  近日,生命科學研究領域再傳喜訊!我國科學家通過國際權威期刊《自然》雜誌上線發表了關於早期肝細胞癌蛋白質組研究領域取得突破的論文,發現了肝細胞癌精準治療的潛在新靶點。
  • 西湖大學揭示新冠患者蛋白質分子病理全景圖
    北京時間1月9日,西湖大學生命科學學院特聘研究員郭天南帶領的課題組與合作團隊在《細胞》期刊在線發表最新研究論文,報告了新冠肺炎病亡患者體內多器官組織樣本中蛋白質分子病理全景圖。此項研究相當於他們將醫生在顯微鏡下看到的人體感染新冠病毒後細胞組織的變化放大了數萬倍,達到蛋白質分子層面,「看」清楚是哪些分子的改變導致人體器官的病變和衰竭。新冠逝者體內有5336個蛋白質分子發生改變大量臨床診療和研究顯示,新冠病人的肺部等器官產生了損傷。這些損傷背後的分子機制到底是什麼樣的?
  • 青年才俊上演計算蛋白質組學頭腦風暴——記CNCP 2016新技術
    記第四屆中國計算蛋白質組學研討會(CNCP-2016)新技術  儀器信息網訊 2016年8月10日-11日,第四屆中國計算蛋白質組學研討會n-square和交聯肽段低效裂解這兩大難題,該研究組建立了一種新XL-MS工作流-質譜可分裂交聯劑法。
  • Theranostics報導:基於血液蛋白質組學的中醫藥精準醫學研究
    鳳凰中心於曉波研究員、廣東省中醫院盧傳堅教授、西湖大學郭天南研究員和南京大學許丹科教授等合作,運用蛋白質組學對中醫藥治療銀屑病展開研究,找到與疾病密切相關的血清蛋白標誌物分子,有望用於銀屑病的早期檢測、嚴重程度評估及復發評估。
  • 中國首繪新冠逝者蛋白質分子病理全景圖:含肝、睪丸等多器官
    研究報告了2020年初因新冠肺炎去世的患者體內多器官組織樣本中蛋白質分子病理全景圖,有助於較深入認識新冠致死機理,及對患者進行精準的幹預治療。這是在全球範圍內第一次從蛋白質分子水平上,對新冠病毒感染人體後多個關鍵器官做出的響應進行了詳細和系統的分析,為臨床工作者和研究人員制定治療方案、開發新的藥物及治療方法提供了線索和依據。
  • 第八屆陸表衛星遙感數據反演理論與方法暑期學校通知(第一輪)
    背景和目標  過去幾十年裡,遙感技術的進步極大地提高了遙感數據產品的科學應用潛力。為了更好的滿足社會需求,改進在全球到區域不同尺度上的模型預測能力,輔助各類決策支持系統的決策制定,大量衛星數據需要進一步轉化為高級產品。通過數據中心發布更多的高級產品而非簡單的初級衛星影像已經成為了一種總體趨勢。
  • IF:12.1跨實驗室比較基於DIA的蛋白質組學質譜工作流程穩定性潛力
    然而僅僅依靠基因組學的數據,無法為臨床決策(clinical decision)提供足夠的支持,其他數據例如蛋白質組學(proteomics) 數據、健康科學(healthcare)數據等依然需要被納入到精準醫學的數據處理之中。
  • 我國科學家首次揭示新冠肺炎患者蛋白質分子病理全景圖
    (記者晉浩天)西湖大學生命科學學院郭天南課題組與華中科技大學同濟醫學院附屬協和醫院胡豫、夏家紅、聶秀團隊日前在《細胞》在線發表了題為《新冠肺炎死亡患者多器官蛋白質組全景圖》的最新研究論文,指示了2020年年初因新冠肺炎去世的患者體內多器官組織樣本中蛋白質分子病理全景圖
  • 從基因組大數據到精準醫學(開卷知新)
    20世紀90年代初,「人類基因組計劃」正式啟動,開啟人類在分子水平上認識自身遺傳密碼的新航程。2001年,人類基因組精細圖譜及其初步分析結果發布,使我們看到由四種符號組成的一維人類遺傳密碼的真實面貌。人類基因組研究促成基因檢測等一系列新技術出現,還帶來基因診斷、基因治療、靶向藥物等醫學新手段,生物醫學進入建立在基因組大數據基礎上的精準醫學時代。
  • 植物所舉辦「第五屆植物分類高級培訓班」
    植物所舉辦「第五屆植物分類高級培訓班」 2019-10-11 植物研究所 【字體:>R語言獲取物種大數據和研究」、「植物分類修訂思路和方法」、「菊科植物系統發生研究進展」、「葡萄科植物系統發生與分類學研究」、「運用淺層基因組數據開展蘭科植物系統學研究」、「系統基因組學重建揭示系統樹的內在衝突」、「物種概念和相關研究」、「第三代測序儀的技術原理及其在植物研究中的應用」
  • 《新英格蘭醫學雜誌》背靠背發表羅沙司他中國臨床研究
    中新網上海新聞8月14日電 (記者 陳靜)記者14日獲悉,全球頂尖醫學期刊《新英格蘭醫學雜誌